Abstract

Small heterodimer partner (SHP) is an orphan nuclear receptor that lacks a conventional DNA binding domain. It interacts with several other members of the nuclear receptor superfamily and inhibits receptor transactivation. In order to characterize the regulation of SHP expression, a number of receptors and other transcription factors were tested for effects on the SHP promoter. Among these, the orphan receptor steroidogenic factor-1 (SF-1) was found to potently transactivate the SHP promoter. Detailed footprinting studies show that the SHP promoter contains at least five SF-1 binding sites, and mutagenesis studies demonstrate each of the three strongest binding sites is required for SF-1 transactivation. SHP is coexpressed with SF-1 in adrenal glands, but is also expressed in tissues that lack SF-1, including liver. However, liver expresses a close relative of SF-1, the orphan fetoprotein transcription factor (FTF), and FTF can also transactivate the SHP promoter. These results suggest that alterations in the levels or activities of SF-1 or FTF could modulate SHP expression in appropriate tissues and thereby affect a variety of receptor dependent signaling pathways.

Highlights

  • Small heterodimer partner (SHP) is an orphan nuclear receptor that lacks a conventional DNA binding domain

  • A variety of nuclear hormone receptors and other transcription factors were tested for ability to stimulate the SHP promoter in transient transfection

  • In Y1 cells, which have been routinely used for studies of steroidogenic factor-1 (SF-1) transactivation [16], SF-1 expression increased SHP promoter activity by approximately 5-fold, whereas the TKluc reporter, which contains the thymidine kinase (TK) promoter from herpes simplex virus, did not respond to SF-1 (Fig. 1A)

Read more

Summary

EXPERIMENTAL PROCEDURES

Plasmids—Various reporter constructs for the mouse and human SHP promoters were prepared by insertion of polymerase chain reaction-amplified 5Ј-flanking regions of the two genomic DNAs into a previously described luciferase reporter [14]. Preparation of 5Ј deletion constructs of mouse SHP promoter has been described elsewhere [15]. Point mutations were introduced into the SHP(Ϫ453)luc reporter using

Activation of the SHP Promoter
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call